Immunotherapeutic Vaccine Candidate Fast Tracked for Alzheimer Disease
UB-311 is an immunotherapeutic vaccine candidate that targets toxic forms of aggregated amyloid beta in the brain.
Diagnosis & Disease Information
Novel Plasma Biomarkers May Improve Prediction of Alzheimer Disease
Researchers established the Florida Consortium for African American Alzheimer’s Disease Studies to identify genetic risk factors and novel plasma biomarkers for AD.
Subcutaneous Anti-Amyloid Beta Antibody Fast Tracked for Alzheimer Disease
In preclinical studies, PRX012 has been shown to bind to beta amyloid plaques and oligomers with high affinity.
Caffeine Intake and Dementia: Can Lewy Bodies Explain the Link?
Researchers sought to investigate the associations between habitual caffeine intake, incident cognitive impairment, and neuropathology.
Mortality Rates Rose During COVID-19 Among Medicare Beneficiaries With Dementia
In a cross-sectional study, researchers compared COVID-19 infection and mortality rates from 2019 and 2020 among Medicare enrollees with Alzheimer disease and related dementias.
AAN Calls for More Guidance for Aducanumab Use in Alzheimer Disease
Researchers sought to review the available clinical trial data that details the use of aducanumab in individuals with early symptomatic AD and provide clinical considerations regarding its use.
Donepezil Transdermal Patch Approved for Alzheimer Disease
Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion.
FDA Sets Date for Decision on Pimavanserin for Alzheimer Disease Psychosis
Acadia Pharmaceuticals resubmitted the sNDA after addressing issues raised in a Complete Response Letter issued by the Agency.
Does Air Pollution Cause Dementia? Here’s What We Know So Far
Jiu-Chiuan Chen, MD, ScD and Diana Younan, PhD, MPH discuss the importance of understanding the relationship between air pollution and dementia risk and how clinicians can help patients mitigate their risk.
Persistent Loneliness May Increase 10-Year Risk for Dementia
Researchers sought to determine the association of loneliness with 10-year all-cause dementia risk and the cross-sectional association of loneliness with early markers of Alzheimer disease and related dementia vulnerability.
- Loading...
Loading...
Next post in Neurology
Loading... 
Loading...